secwatch.observer — SEC 8-K summary
======================================

Issuer:     DANAHER CORP /DE/ (DHR)
CIK:        0000313616
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0000313616-25-000155
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Danaher names Matthew Gugino as CFO effective Feb 28, 2026; McGrew to remain EVP
--------------------------------------------------------------------------------

- Matthew M. McGrew to step down as CFO effective Feb 28, 2026, continue as Executive Vice President.
- Matthew E. Gugino, currently Group CFO of Life Sciences Innovations, appointed CFO effective Feb 28, 2026.
- Gugino's base salary increases to $700k now, $825k upon CFO start; equity target $4.2M in 2026.
- McGrew's 2026 compensation: base salary $700k, target bonus 125%, equity $2.5M.
- Gugino joined Danaher in 2013; previously at Barclays, Morgan Stanley, KPMG.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313616/000031361625000155/0000313616-25-000155-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313616/000031361625000155/dhr-20250721.htm
  HTML page:      https://secwatch.observer/filing/0000313616-25-000155

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer